(Boston, MA: Rhythm Therapeutics (2024)
Pharmacy chains report more consistent stock than early shortage periods, but patient access still hinges on insurance approval, prior authorization requirements, and regional pharmacy networks
However, proteins within cells can fold incorrectly
This creates a frustrating situation where the most effective treatments are only accessible to people who can afford to pay out of pocket
Evidence strength: Weak to moderate
Its part of a bigger picture that includes hormone support, sleep, and stress reduction. What the Latest Research Shows Evidence-Based and Backed by Science A 2024 study in The New England Journal of Medicine shows that patients on GLP-1 medications continued to lose weight for over a yearwith long-term maintenance when paired with expert oversight and lifestyle support